Showing results (271-280 of 422) with videos related to

Sort By:
Pageof 43
International Journal of Radiation Oncology, Biology, Physics|June 26, 2022
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and ImmunotherapyMark C Korpics, Rohan R Katipally, Julien Partouche, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case seriesSowmya Ravi, Kristen Spencer, Mary Ruisi, et al.
The Lancet. Infectious Diseases|August 30, 2017
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy studyChristina Yoon, Fred C Semitala, Elly Atuhumuza, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responsesLiyun Chen, Victoria Shi, Songyan Wang, et al.
JAMA Network Open|February 17, 2026
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical TrialSancy A Leachman, Jason J Luke, Paolo A Ascierto, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2025
WDFY4-dependent cross-presentation proceeds via a vacuolar antigen-processing routeJ Luke Postoak, Alyssa Koch, Sicong Shan, et al.
Autophagy Reports|July 29, 2024
A fluorescent reporter for rapid assessment of autophagic flux reveals unique autophagy signatures during <i>C. elegans</i> post-embryonic development and identifies compounds that modulate autophagyZachary D Dawson, Hemalatha Sundaramoorthi, Suk Regmi, et al.
Cancer Immunology Research|April 5, 2017
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma PatientsMarlene Garcia-Neuer, Melina E Marmarelis, Sushrut R Jangi, et al.
Human Molecular Genetics|May 20, 2014
A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiencyLinda P O'Reilly, Olivia S Long, Murat C Cobanoglu, et al.
The Journal of Biological Chemistry|June 15, 2007
SERPINB11 is a new noninhibitory intracellular serpin. Common single nucleotide polymorphisms in the scaffold impair conformational changeDavid J Askew, Sule Cataltepe, Vasantha Kumar, et al.
Pageof 43